Genetics in Drug Discovery

Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Her...

Full description

Saved in:
Bibliographic Details
Published in:Trends in genetics 2021-07, Vol.37 (7), p.603-605
Main Authors: Hubaud, Alexis, Singh, Ajeet Pratap
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c253t-deb87f0c7102983abcab662d808cab141b5b4484416149d83b08967e8c4004893
container_end_page 605
container_issue 7
container_start_page 603
container_title Trends in genetics
container_volume 37
creator Hubaud, Alexis
Singh, Ajeet Pratap
description Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Here, we examine how genetics can be leveraged in drug discovery to understand and alter human biology.
doi_str_mv 10.1016/j.tig.2021.04.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2518989201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2518989201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-deb87f0c7102983abcab662d808cab141b5b4484416149d83b08967e8c4004893</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRb0A0VL4AFigLNkkzPiR2EvUloJUiQ2srdhxqkR5FDtB6t-T0sJqRqN7j0aHkDuEBAHTpzoZql1CgWICPAHACzKf7jJWgooZuQ6hBgCRMXFFZowpoIplc3K_cZ0bKhuiqotWftxFqyrY_tv5ww25LPMmuNvzXJDPl_XH8jXevm_els_b2FLBhrhwRmYl2AwnpGS5sblJU1pIkNOGHI0wnEvOMUWuCskMSJVmTloOwKViC_J44u59_zW6MOh2esE1Td65fgyaCpRKKgo4RfEUtb4PwbtS733V5v6gEfRRg671pEEfNWjgGn47D2f8aFpX_Df-HLAfgzdYaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2518989201</pqid></control><display><type>article</type><title>Genetics in Drug Discovery</title><source>ScienceDirect Freedom Collection</source><creator>Hubaud, Alexis ; Singh, Ajeet Pratap</creator><creatorcontrib>Hubaud, Alexis ; Singh, Ajeet Pratap</creatorcontrib><description>Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Here, we examine how genetics can be leveraged in drug discovery to understand and alter human biology.</description><identifier>ISSN: 0168-9525</identifier><identifier>DOI: 10.1016/j.tig.2021.04.001</identifier><identifier>PMID: 33902937</identifier><language>eng</language><publisher>England</publisher><ispartof>Trends in genetics, 2021-07, Vol.37 (7), p.603-605</ispartof><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c253t-deb87f0c7102983abcab662d808cab141b5b4484416149d83b08967e8c4004893</cites><orcidid>0000-0003-1249-4282 ; 0000-0002-3819-5136</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33902937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hubaud, Alexis</creatorcontrib><creatorcontrib>Singh, Ajeet Pratap</creatorcontrib><title>Genetics in Drug Discovery</title><title>Trends in genetics</title><addtitle>Trends Genet</addtitle><description>Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Here, we examine how genetics can be leveraged in drug discovery to understand and alter human biology.</description><issn>0168-9525</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRb0A0VL4AFigLNkkzPiR2EvUloJUiQ2srdhxqkR5FDtB6t-T0sJqRqN7j0aHkDuEBAHTpzoZql1CgWICPAHACzKf7jJWgooZuQ6hBgCRMXFFZowpoIplc3K_cZ0bKhuiqotWftxFqyrY_tv5ww25LPMmuNvzXJDPl_XH8jXevm_els_b2FLBhrhwRmYl2AwnpGS5sblJU1pIkNOGHI0wnEvOMUWuCskMSJVmTloOwKViC_J44u59_zW6MOh2esE1Td65fgyaCpRKKgo4RfEUtb4PwbtS733V5v6gEfRRg671pEEfNWjgGn47D2f8aFpX_Df-HLAfgzdYaw</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Hubaud, Alexis</creator><creator>Singh, Ajeet Pratap</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1249-4282</orcidid><orcidid>https://orcid.org/0000-0002-3819-5136</orcidid></search><sort><creationdate>20210701</creationdate><title>Genetics in Drug Discovery</title><author>Hubaud, Alexis ; Singh, Ajeet Pratap</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-deb87f0c7102983abcab662d808cab141b5b4484416149d83b08967e8c4004893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hubaud, Alexis</creatorcontrib><creatorcontrib>Singh, Ajeet Pratap</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hubaud, Alexis</au><au>Singh, Ajeet Pratap</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetics in Drug Discovery</atitle><jtitle>Trends in genetics</jtitle><addtitle>Trends Genet</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>37</volume><issue>7</issue><spage>603</spage><epage>605</epage><pages>603-605</pages><issn>0168-9525</issn><abstract>Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Here, we examine how genetics can be leveraged in drug discovery to understand and alter human biology.</abstract><cop>England</cop><pmid>33902937</pmid><doi>10.1016/j.tig.2021.04.001</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1249-4282</orcidid><orcidid>https://orcid.org/0000-0002-3819-5136</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0168-9525
ispartof Trends in genetics, 2021-07, Vol.37 (7), p.603-605
issn 0168-9525
language eng
recordid cdi_proquest_miscellaneous_2518989201
source ScienceDirect Freedom Collection
title Genetics in Drug Discovery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A40%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetics%20in%20Drug%20Discovery&rft.jtitle=Trends%20in%20genetics&rft.au=Hubaud,%20Alexis&rft.date=2021-07-01&rft.volume=37&rft.issue=7&rft.spage=603&rft.epage=605&rft.pages=603-605&rft.issn=0168-9525&rft_id=info:doi/10.1016/j.tig.2021.04.001&rft_dat=%3Cproquest_cross%3E2518989201%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c253t-deb87f0c7102983abcab662d808cab141b5b4484416149d83b08967e8c4004893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2518989201&rft_id=info:pmid/33902937&rfr_iscdi=true